Research location

Herlev

Denmark

Published trials313

Site observations323

Linked trials published313

Page1 / 7

Research activity in Herlev

Denmark

CureCurrent currently publishes aggregate city-level research activity for this location: 313 trials and 323 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Herlev

313 linked trials · page 1 of 7

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes MellitusNCT07776509 · 2026-08-24 · 2 site observations

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)NCT07227805 · 2026-07-19 · 1 site observation

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background DapagliflozinNCT07662135 · 2026-07-06 · 1 site observation

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes MellitusNCT07662044 · 2026-07-06 · 1 site observation

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusNCT07662109 · 2026-07-06 · 1 site observation

Changing Outpatient Diabetes Care With Remote-Patient-Monitoring: A Real World Evidence Study With Pre-Post ComparisonNCT07617519 · 2026-06-10 · 1 site observation

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityNCT07567001 · 2026-05-11 · 1 site observation

The Postprandial Hypo-Avoid StudyNCT07427251 · 2026-04-27 · 1 site observation

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainNCT07509307 · 2026-04-20 · 1 site observation

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainNCT07481630 · 2026-04-13 · 1 site observation

Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging StudyNCT07482072 · 2026-03-01 · 1 site observation

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightNCT07353931 · 2026-02-09 · 1 site observation

Disentangling the Effect of Brain Insulin Resistance on Brain HealthNCT07374705 · 2026-01-01 · 1 site observation

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 DiabetesNCT07187531 · 2025-11-25 · 1 site observation

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerNCT06793215 · 2025-10-24 · 1 site observation

An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)NCT07206056 · 2025-10-15 · 1 site observation

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or ObesityNCT07037433 · 2025-07-25 · 1 site observation

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseaseNCT07064473 · 2025-07-22 · 2 site observations

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLCNCT06765109 · 2025-07-17 · 1 site observation

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityNCT07037459 · 2025-06-25 · 1 site observation

The Role of the Amylin Analogue Cagrilintide in Bone MetabolismNCT07010432 · 2025-06-12 · 1 site observation

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartNCT06935370 · 2025-05-20 · 1 site observation

Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN StudyNCT06906081 · 2025-05-02 · 1 site observation

FDG-PET/CT vs. CT for Monitoring Metastatic Breast CancerNCT06877949 · 2025-04-02 · 1 site observation

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerNCT06989112 · 2025-03-27 · 1 site observation

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinNCT06677060 · 2025-03-14 · 1 site observation

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureNCT06742723 · 2025-03-03 · 1 site observation

Efficacy and Safety of KBP-336 in Obese Individuals with OsteoarthritisNCT06833749 · 2025-01-28 · 1 site observation

Birth & Breastfeeding Support StudyNCT06844019 · 2025-01-06 · 1 site observation

PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)NCT07263490 · 2024-10-21 · 1 site observation

A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health RecordNCT06642272 · 2024-10-10 · 2 site observations

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery DiseaseNCT06606821 · 2024-10-01 · 1 site observation

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid ArthritisNCT06671054 · 2024-10-01 · 1 site observation

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 DiabetesNCT06082063 · 2024-07-01 · 1 site observation

Cognitive Screening and Multidomain Intervention Targeting Cognitive Decline in Type 2 Diabetes (The Brain Care Study)NCT07250789 · 2024-06-01 · 1 site observation

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)NCT05485961 · 2024-04-27 · 1 site observation

Integrated Approach in Frail Older People with Atrial FibrillationNCT06775028 · 2024-04-11 · 1 site observation

STRONG for Surgery & Strong for Life - Intensive Prehabilitation for Risk Reduction in Ventral Hernia RepairNCT06611462 · 2024-03-04 · 1 site observation

DESTINY Breast Respond HER2-(Ultra)Low EuropeNCT05945732 · 2023-10-24 · 1 site observation

DECONGEST-AHF: Vasodilatation or Loop Diuretics in Acute Heart FailureNCT05276219 · 2023-09-14 · 1 site observation

A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).NCT05354596 · 2022-11-01 · 1 site observation

Imaging Versus Cardiac Biomarker Monitored HER2 Directed Therapy in Patients With Breast CancerNCT05406635 · 2021-10-01 · 1 site observation

Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)NCT04611867 · 2021-08-17 · 1 site observation

Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive FactorsNCT04916132 · 2021-08-10 · 1 site observation

When to INDuce for OverWeight? (WINDOW)NCT04603859 · 2020-10-19 · 1 site observation

The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast CancerNCT04291378 · 2020-06-01 · 1 site observation

National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer PatientsNCT04086290 · 2019-10-10 · 1 site observation

Partial Breast Versus no Irradiation for Women With Early Breast CancerNCT03646955 · 2018-09-05 · 1 site observation

Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant Navelbine®NCT02354274 · 2015-01-01 · 1 site observation

Surgery Versus Radiotherapy for Locally Advanced Prostate CancerNCT02102477 · 2014-10-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.